PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin
Abstract Background Protein tyrosine phosphatase receptor delta (PTPRD) is frequently inactivated in various types of cancers. Here, we explored the underlying mechanism of PTPRD-loss-induced cancer metastasis and investigated an efficient treatment option for PTPRD-inactivated gastric cancers (GCs)...
Main Authors: | Won Jung Bae, Ji Mi Ahn, Hye Eun Byeon, Seokwhi Kim, Dakeun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-019-1469-4 |
Similar Items
-
An integrative prognostic and immune analysis of PTPRD in cancer
by: Chunpei Ou, et al.
Published: (2022-03-01) -
Neural conditional ablation of the protein tyrosine phosphatase receptor Delta PTPRD impairs gliogenesis in the developing mouse brain cortex
by: Francisca Cornejo, et al.
Published: (2024-02-01) -
PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types
by: Xiaoling Shang, et al.
Published: (2022-09-01) -
PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients
by: Hung-Chih Hsu, et al.
Published: (2018-09-01) -
Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC
by: Yiting Sun, et al.
Published: (2021-10-01)